These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 11402971)

  • 1. [Atherosclerosis and blood lipoproteins].
    Faergeman O
    Ugeskr Laeger; 2001 May; 163(21):2924-6. PubMed ID: 11402971
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipoproteins and coronary heart disease.
    Krauss RM
    Postgrad Med; 1989 Apr; Spec No():54-8; discussion 89-90. PubMed ID: 2726627
    [No Abstract]   [Full Text] [Related]  

  • 3. Pediatric primary prevention of atherosclerosis.
    Glueck CJ
    N Engl J Med; 1986 Jan; 314(3):175-7. PubMed ID: 3941697
    [No Abstract]   [Full Text] [Related]  

  • 4. [The use of apolipoprotein B in clinical practice to determine the risk for atherosclerosis].
    Cabezas Castro M; Liem A
    Ned Tijdschr Geneeskd; 2003 Jul; 147(30):1445-8. PubMed ID: 12908345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathogenetic bases of preventing atherosclerosis].
    Chazov EI
    Ter Arkh; 1985; 57(11):29-33. PubMed ID: 4082018
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of dyslipidemias and its benefits].
    Taskinen MR
    Duodecim; 1999; 115(10):1138-44. PubMed ID: 11877853
    [No Abstract]   [Full Text] [Related]  

  • 7. [Atherosclerosis and hypercholesterolemia in pediatric and adolescent medicine].
    Ratzmann GW
    Arztl Jugendkd; 1991; 82(1):41-3. PubMed ID: 1927728
    [No Abstract]   [Full Text] [Related]  

  • 8. [Can higher level of HDL cholesterol augment cardiovascular disease prevention? The combination statins-nicotinic acid increases the level of HDL and reduces the level of LDL cholesterol].
    Carlson LA
    Lakartidningen; 2006 Oct 25-31; 103(43):3283-5. PubMed ID: 17117660
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduced adiponectin and HDL cholesterol without elevated C-reactive protein: clues to the biology of premature atherosclerosis in Hutchinson-Gilford Progeria Syndrome.
    Gordon LB; Harten IA; Patti ME; Lichtenstein AH
    J Pediatr; 2005 Mar; 146(3):336-41. PubMed ID: 15756215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Arteriosclerosis without risk factors?].
    Windler E
    Dtsch Med Wochenschr; 1990 Apr; 115(16):636-7. PubMed ID: 2328671
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation.
    Brunzell JD; Davidson M; Furberg CD; Goldberg RB; Howard BV; Stein JH; Witztum JL
    J Am Coll Cardiol; 2008 Apr; 51(15):1512-24. PubMed ID: 18402913
    [No Abstract]   [Full Text] [Related]  

  • 12. [High cholesterol level may protect against infections and probably also atherosclerosis].
    Ravnskov U
    Lakartidningen; 2004 Mar; 101(13):1215-7; discussion 1218, 1221-2. PubMed ID: 15101249
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of lipids, lipoproteins and apolipoproteins concentrations in cord blood serum of newborns from rural and urban environments.
    Pac-Kozuchowska E
    Ann Agric Environ Med; 2007; 14(1):25-9. PubMed ID: 17655173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Subclinical hypothyroidism and arteriosclerosis].
    Földes J; Bános C; Winkler G
    Orv Hetil; 2004 Aug; 145(31):1601-7. PubMed ID: 15384857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lower LDL and/or raise HDL. In what direction is lipidology moving?].
    Parhofer KG
    MMW Fortschr Med; 2007 May; 149(22):27. PubMed ID: 18069222
    [No Abstract]   [Full Text] [Related]  

  • 16. [Considerable remaining risk in unchecked LDL lowering. Is the HDL increase the way out?].
    MMW Fortschr Med; 2006 Jun; 148(24):6, 8. PubMed ID: 16856232
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lipid disturbances in the nephrotic syndrome].
    Chmielewski M; Zdrojewski Z; Rutkowski B
    Przegl Lek; 2003; 60(11):758-61. PubMed ID: 15058052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy.
    Feeman WE
    Circulation; 2003 May; 107(20):e199. PubMed ID: 12777330
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lipoprotein metabolism and atherosclerosis--experimental principles].
    Hüttinger M; Dudczak R
    Vasa Suppl; 1987; 20():52-5. PubMed ID: 3480607
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipids and atherosclerosis. A two-pronged approach to treatment.
    Tzagournis M
    Postgrad Med; 1987 May; 81(6):242-9, 252. PubMed ID: 3575196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.